TheStreet3d agobullish
JPMorgan aggressively double-upgrades another AI stock by 41%Here’s what could happen to IREN shares next.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
77last 24h
978last 7d
110● bullish (7d)
126● bearish (7d)
212publishers
Investing.com100d agobullish
Illumina upgraded to overweight at JPMorgan on clinical demand outlookInvesting.com -- Illumina received a bullish rating upgrade from JPMorgan, which raised its recommendation to Overweight from Neutral and lifted its December 2026 price target to $185 from $125, citing growing confidence in the DNA sequencing company's ability to sustain strong growth despite increasing competition.